ENTITY
JD Health International

JD Health International (6618 HK)

376
Analysis
Consumer StaplesChina
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
05 Apr 2021 22:14

We Doctor IPO Initiation: Patient Revolution

We Doctor was filed for an HKEx IPO to raise around $2-3 bn. For investors willing to brave the IPO markets, We Doctor is an attractive play on the...

Logo
390 Views
Share
05 Apr 2021 12:29

JD Health (6618 HK): 2H20, Faster Than 1H20 and Alibaba Health

JD Health’s revenue growth rate accelerated to 81% yoy in 2H20, compared to 76% yoy in 1H20. JD Health’s product revenue grew more rapidly than...

Logo
Ming Lu
348 Views
Share
04 Apr 2021 09:19

China Healthcare Weekly (Apr.2)

This article analyzed the upcoming 5th volume-based purchase, the "Internet +" medical insurance payment, the specialized hospital market...

Logo
271 Views
Share
30 Mar 2021 04:30

JD Health 2020 Results: Strong Top Line Growth; Slight Decline in Margins Is Less of a Concern

JD Health’s 2020 results prove that the company’s business is sustainable beyond Covid-19 as evidenced by strong growth in revenues during the...

Share
27 Mar 2021 04:56

Asia Short Interest: Xinyi Solar, Alibaba, Tencent, ENEOS, Resona, Toshiba, Samsung, TSMC, Yageo

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
366 Views
Share
x